Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. How Dupixent is establishing itself as the premier dermatology treatment
  2. Epilepsy drug sales to hit $7.5bn by 2026
  3. Billion-dollar deals mean bright future for Takeda
  4. European Commission approves AstraZeneca’s Fasenra for asthma
  5. M&As this week: CSPC NBP Pharmaceutical, International Finance Corporation, Sun Pharmaceutical

Latest Content

Worker Preferences and Workplace Agility

Worker Preferences and Workplace Agility canvasses the value employees attach to key elements of their work, including skills, flexible work arrangements, and even the idea of socially conscious work.

Billion-dollar deals mean bright future for Takeda

Takeda has taken a massive step forward in its partnership and acquisition deals over the past year, totaling over a billion dollars. Their CEO, Christophe Weber, stated that the company’s goal is to become more versatile and diverse, hence its deals with biotechnology firms, while still holding the financial punch of a Big Pharma company.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top